KJ77
11-02-2008, 12:01 AM
The FDA has approved lacosamide as add-on therapy for adults with partial-onset seizures, and 2 new dosage strengths of a compound combining levodopa, carbidopa, and entacapone, indicated for Parkinson's disease patients who experience end-of-dose wearing-off.
Medscape Medical News
More... (http://www.medscape.com/viewarticle/582892?src=rss)
Medscape Medical News
More... (http://www.medscape.com/viewarticle/582892?src=rss)